Lipoadenoma of the parathyroid: characteristics of a rare cause of hyperparathyroidism
- PMID: 35691821
- DOI: 10.1507/endocrj.EJ22-0118
Lipoadenoma of the parathyroid: characteristics of a rare cause of hyperparathyroidism
Abstract
Parathyroid Lipoadenoma (PLA) contains abundant mature adipose tissue and is a rare cause of hyperparathyroidism. This study aimed to investigate the clinical features of PLA in nine patients with primary hyperparathyroidism, including two men and seven women, with ages ranging from 45-84 years (median 60 years). PLA accounted for 0.5% of all parathyroid tumors during the study period. One patient presented with anorexia due to hypercalcemia; however, the other eight patients were asymptomatic. The median preoperative serum intact-parathyroid hormone (iPTH) and calcium levels were 143 pg/mL (range, 102-378) and 10.8 mg/dL (range, 10.3-11.3), respectively. PLA was difficult to identify using ultrasonography (US) as it appears as a moderately hyperechoic nodule and is difficult to distinguish from the surrounding adipose tissues. Only 33% of the lesions (three out of nine lesions) were accurately identified. However, they could be distinctly differentiated from the surrounding tissue using computed tomography (CT). All PLAs were also detected using the sesta-methoxyisobutylisonitrile single-photon emission-computed tomography (SPECT). All the patients were treated by a single gland extirpation. The median size and weight of the PLA were 14 mm (range, 10-22) and 567 mg (range, 200-1,533), respectively. In conclusion, the clinical manifestations of PLA are similar to those of ordinal parathyroid adenomas, except for their unique US and CT images. PLA should be considered as a potential etiologic factor in cases of hyperparathyroidism when the lesions are demonstrated as hyperechoic nodules or unidentified by US but detected by CT or SPECT imaging.
Keywords: Diagnostic imaging; Hyperparathyroidism; Parathyroid lipoadenoma.
Similar articles
-
The Usefulness of Maximum Standardized Uptake Value at the Delayed Phase of Tc-99m sestamibi single-photon emission computed tomography/computed tomography for Identification of Parathyroid Adenoma and Hyperplasia.Medicine (Baltimore). 2020 Jul 10;99(28):e21176. doi: 10.1097/MD.0000000000021176. Medicine (Baltimore). 2020. PMID: 32664158 Free PMC article.
-
Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.Invest Radiol. 1997 Aug;32(8):459-65. doi: 10.1097/00004424-199708000-00005. Invest Radiol. 1997. PMID: 9258734
-
Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia.Nucl Med Commun. 2018 Dec;39(12):1129-1137. doi: 10.1097/MNM.0000000000000921. Nucl Med Commun. 2018. PMID: 30239472 Free PMC article.
-
Multimodality imaging of the parathyroid glands in primary hyperparathyroidism.Minerva Endocrinol. 2008 Sep;33(3):193-202. Minerva Endocrinol. 2008. PMID: 18846025 Review.
-
Technetium-99m tetrofosmin parathyroid imaging in patients with primary hyperparathyroidism.Intern Med. 2000 Feb;39(2):101-6. doi: 10.2169/internalmedicine.39.101. Intern Med. 2000. PMID: 10732824 Review.
Cited by
-
Impact of adipocytes on ultrasound evaluation of parathyroid adenomas.J Med Ultrason (2001). 2025 Apr;52(2):237-243. doi: 10.1007/s10396-024-01511-2. Epub 2024 Dec 28. J Med Ultrason (2001). 2025. PMID: 39731664 Free PMC article.